Agennix discloses interim data from first-in-human trial of RGB-286638 in hematologic tumors Dec. 3, 2010
Elara Pharma's new antitumor agent EL-102 inhibits HIF-1-alpha and cellular proliferation Dec. 2, 2010
Multikinase inhibitor AI-1008 shows promise to treat chronic myeloid leukemia in preclinical testing Dec. 1, 2010
RSS